EBITDA Margin % is calculated as EBITDA divided by its Revenue. Motus GI Holdings's EBITDA for the
three
months ended in Dec. 2023 was $-2.59 Mil. Motus GI Holdings's Revenue for the
three
months ended in Dec. 2023 was $0.06 Mil. Therefore, Motus GI Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was -4,048.44%.
Motus GI Holdings EBITDA Margin % Historical Data
The historical data trend for Motus GI Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Motus GI Holdings's EBITDA Margin %
For the Medical Devices subindustry, Motus GI Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Motus GI Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Motus GI Holdings's EBITDA Margin % falls into.
Motus GI Holdings EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Motus GI Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Motus GI Holdings (OTCPK:MOTS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Motus GI Holdings EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Motus GI Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Motus GI Holdings (Motus GI Holdings) Business Description
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MOTS has been successfully added to your 